|
(1)
|
I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Seelos
Therapeutics, Inc.; and
|
|
(2)
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements
made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|
|
Dated: April 29, 2024
|
By:
|
/s/ Michael Golembiewski
|
|
Michael Golembiewski
|
||
|
Chief Financial Officer
|
||
|
(Principal Financial Officer)
|